JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area pi3k akt signaling pi3k inhibitors'

Search results for: 'research area pi3k akt signaling pi3k inhibitors'

B3672 Indirubin

Target: Cyclin-Dependent Kinases|GSK-3

Summary: cyclin-dependent kinases and GSK-3β inhibitor

insoluble in H2O; insoluble in H2O; insoluble in EtOH; ≥13.1 mg/mL
A3417 Flavopiridol

Target: Cyclin-Dependent Kinases

Summary: Pan-cdk inhibitor

insoluble in H2O; ≥40.2 mg/mL
A8412 Dinaciclib (SCH727965)

2 Citation

Target: Cyclin-Dependent Kinases

Summary: Potent CDK inhibitor
A8642 R547

2 Citation

Target: Cyclin-Dependent Kinases

Summary: CDK1/2/4 inhibitor,ATP-competitive

Soluble in DMSO
A1794 LY2835219

Target: Cyclin-Dependent Kinases

Summary: CDK4/6 inhibitor,potent and selective

≥30.15 mg/mL
A8335 Palbociclib (PD0332991) Isethionate

1 Citation

Target: Cyclin-Dependent Kinases

Summary: CDK4/6 inhibitor,highly selective

≥28.7 mg/mL
A8885 Ro 3306

4 Citation

Target: Cyclin-Dependent Kinases

Summary: An ATP-competitive, potent CDK1 inhibitor

insoluble in EtOH; insoluble in H2O; ≥4.39 mg/mL
A4115 JNJ-7706621

1 Citation

Target: Cyclin-Dependent Kinases|Aurora Kinases

Summary: Potent CDK/Aurora kinase inhibitor

insoluble in EtOH; insoluble in H2O; ≥19.7 mg/mL
A8326 AZD-5438

2 Citation

Target: Cyclin-Dependent Kinases

Summary: Potent CDK1/2/9 inhibitor

insoluble in H2O; ≥18.55 mg/mL
A8501 PHA-848125

Target: Cyclin-Dependent Kinases

Summary: CDK inhibitor,potent and ATP-competitive

≥23.05 mg/mL